Circulating proalbumin associated with a variant proteinase inhibitor.
The unique finding of normal proalbumin in human plasma provides an insight into the mechanism of propeptide cleavage. Proalbumin, present as 1-5% of the total albumin, was found in a boy whose prime problem was the presence of a mutant proteinase inhibitor, alpha 1-antitrypsin Pittsburgh (358 Met----Arg) [2]. The inferred structure of human proalbumin was confirmed as Arg-Gly-Val-Phe-Arg-Arg-Alb. On incubation with various enzymes (trypsin, tryptase, thrombin, chymotrypsin, chymase and cathepsin B), only trypsin was capable of converting proalbumin to albumin. There was no conversion when proalbumin was incubated with whole blood, plasma or serum. However, intravenous injection of proalbumin into a rat resulted in complete conversion to albumin, the half-life of this process being 6 h. We conclude that propeptide cleavage is dependent on a serine proteinase which is inhibited intracellularly, by the mutant inhibitor, and that all the albumin in the boy was secreted as proalbumin, but was subjected to a separate cleavage process after export from the hepatocyte.
D000293:Adolescent; D000595:Amino Acid Sequence; D000818:Animals; D004587:Electrophoresis, Agar Gel; D006801:Humans; D008297:Male; D011228:Prealbumin / Q000378:metabolism*; D051381:Rats; D012709:Serum Albumin / Q000096:biosynthesis; D000515:alpha 1-Antitrypsin / Q000378:metabolism*
D011228:Prealbumin; D012709:Serum Albumin; D000515:alpha 1-Antitrypsin; C038915:alpha 1-antitrypsin Pittsburgh